600351.SHG Yabao Pharmaceutical Group Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
7.08 CNY
Close of Nov 5, 2026
5.60 7.45
Market cap
CNY 4.90B
P/E
13.6x
P/B
1.75x
ROE
12.4%
Dividend yield
4.32%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600351.SHG undervalued?

Graham number
Price7.08
Graham value6.87
Premium3.0%

600351.SHG trades 3.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Yabao Pharmaceutical Group Co Ltd fundamental analysis

No fundamental analysis for Yabao Pharmaceutical Group Co Ltd yet.

Yabao Pharmaceutical Group Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Yabao Pharmaceutical Group Co Ltd

Yabao Pharmaceutical Group Co., Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, analgesics, psychotropic drugs, women's health products, patches, and general health products. The company was founded in 1978 and is based in Beijing, China.

Full company profile